drug · antibody
leronlimab
Phase 2updated 3mo agoby $CYDY CytoDyn Inc.🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 7 investigational indications.
indications
indications
NSCLCMelanoma
targets
C-C chemokine receptor type 5
all catalysts(0)
nothing on the calendar yet
Trials studying leronlimab
- phase2The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER)
- —An Open-Label, Multicenter, Non-Randomized Expanded Access Protocol (EAP) Designed to Provide Leronlimab to Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer (mTNBC)
- phase2Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors
- phase2Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19
- phase2Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC
- —A Compassionate Use Study of Leronlimab in Breast Cancer
- phase2Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that